EV/EBITDA
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| EV/EBITDA | - | – | – | – | – | – | – | – | |
| Price | $97.07 | +0.1% | +14.7% | +21.2% | +23.0% | +29.8% | +55.2% | +68.2% | |
| PE Ratio | 18.78 | +0.1% | +14.7% | +21.2% | +12.1% | +48.2% | +15.0% | +62.2% | |
| TTM Revenue | $77.59B | +0.7% | – | +0.7% | – | +5.6% | +12.8% | +19.2% | |
| TTM EPS | $5.17 | +9.8% | – | +9.8% | – | -15.8% | +16.7% | +320.6% | |
| Enterprise Value | $61.20B | +0.1% | +15.1% | +20.1% | +21.8% | +27.4% | +21.1% | +40.6% | |
| TTM EBITDA | - | – | – | – | – | – | – | – | |
| Market Cap | $62B | +0.1% | +14.7% | +19.6% | +20.7% | +25.2% | +31.9% | +25.7% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 44.58 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | -3,250.82 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 3.82 | - |
Formula
Data Sources & References
- MET Official Website www.metlife.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1099219/000109921926000005/0001099219-26-000005-index.htm
- MET Profile on Yahoo Finance finance.yahoo.com/quote/MET
- MET Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/met